Sally Frost
Roosevelt Drive
Oxford, ENG, United Kingdom
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: March 10, 2021
The role of cancer metabolism in defining the success of oncolytic viro-immunotherapy.
Journal: Cytokine & growth factor reviews
Published: June 22, 2020
Attenuation of the Hypoxia Inducible Factor Pathway after Oncolytic Adenovirus Infection Coincides with Decreased Vessel Perfusion.
Journal: Cancers
Published: February 26, 2020
Use of Liquid Patient Ascites Fluids as a Preclinical Model for Oncolytic Virus Activity.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 06, 2019
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.
Journal: Journal for immunotherapy of cancer
Published: June 12, 2019
Antagonism of Glycolysis and Reductive Carboxylation of Glutamine Potentiates Activity of Oncolytic Adenoviruses in Cancer Cells.
Journal: Cancer research
Published: May 09, 2018
Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference.
Journal: Cancer gene therapy
Published: May 01, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026